Impact of Carotid atheroma on cardiovascular risk in Mauritanian hypertensive patients

##plugins.themes.academic_pro.article.sidebar##

Published Feb 7, 2022
Download
pdf
Vol. 100 No. 2 (2022): Issue feb 2022

##plugins.themes.academic_pro.article.main##

Camara Sirakhé
Ba Fatimata G
Hanne Abderrahmane
Ba Houleymata
Zein Horma
Sana Ouali
Barry Fatimata
Ahmed Eba

Abstract

Aim: To determine the prevalence of carotid atheroma in hypertensive patients and assess the levels of cardiovascular risk.

Methods: This is a prospective study that took place in the outpatient department of the National Cardiology Center of Nouakchott over a
period of 6 months (October 2019 to March 2020). Patients with hypertension without complications were included. Patients lost to followup and those whose records were incomplete were excluded from the study.

Results: Out of a total of 171 patients, a total of 93 patients (54.38%) was collected, of which 54.8% were women, 55.9% of the patients in
the series were over 50 years old.The associated cardiovascular risk factors were dominated by dyslipidemia (27.9%), diabetes (20.4%),
smoking (26.8%). hypertension was grade 2 in 47.3% of patients and grade 3 in 52.7% of patients. Left ventricular hypertrophy was noted
in 77.4% of patients. Echo-Doppler of the supra-aortic trunks revealed atherosclerotic plaques in 63.4% of patients.

Conclusion: The prevalence of carotid atheroma in hypertensive patients at high cardiovascular risk level was frequent in our series, it
follows from this to recommend early detection for optimal management.


##plugins.themes.academic_pro.article.details##

References

  1. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten year of fatal cardiovascular disease in Europe: the SCORE project. EurHeart J 2003; 24(11):987-1003.
  2. Assman G, Cullen P, Jossa F, Lewis B, Mancini M. Coronary heart disease: Reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A world wilde view. International task force for the prevention of coronary heart disease. ArteriosclerThrombVascBiol 1999; 19: 1819-24.
  3. Bryan W, Giuseppe M, Wilko S, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. EuropeanHeart Journal ( 2018) 00,1-98.
  4. Gosse P, Papaioannou G, Dubiez P, ReuterS, Lemetayer P. Hypertrophie ventriculaire gauche au cours de l’hypertension artérielle. EMC. 11-301-I-10.
  5. Barnett HJM, Taylor DW, Eliasiw M. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339:1415-25.
  6. Touboul PJ, Vicaut E, Labreuche Jet al. Correlation between the Framingham risk score and intima media thickness: theParoi Artérielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis 2007; 192(2):363-9.
  7. Paul J. Gagne,MD., Jeant Mtchett,MD. David MacForland,MD et al. Can the NACET technique for the measuring carotid stenosis be reliably applied outside the trial.J Vas Surg 1996 ; 24 : 449-5
  8. Christopher J. O’Donnell and Roberto Elosua. Cardiovascular risk factors.Inshigts from Framingham Heart. Rev esp cardiol2008;61(3):299-310
  9. Bianga KP, MonganeIrenge J, Canwa R, et al. Epaisseur intima media carotidienne chez l’hypertendu congolais du Sud Kivu. Ann CardiolAngeiol 2016 ; 65 : 64-70.
  10. Soya, J.J. N’djessan, A Ekouet, Konin, C. Athérosclérose infra clinique dans une population d’hypertendus suivis à l’Institut de Cardiologie d’Abidjan (Côte d’Ivoire). JMV-Journal de Médecine Vasculaire 2017; 42(2), 108.
  11. Babaka K, Sarr SA, Kane AA, et al. Prévalence des porteurs de plaques d’athérome carotidiennes dans la population semi-rurale de Guéoul au Sénégal: enquête sur 1411 sujets. J Mal Vascul 2016; 41: 176-81.
  12. Kanters SD, Algra A, VanLeeuwen MS et al. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28: 665-71.
  13. Monsuez JJ, Mecherour S, Kharchi S. Athérosclérose carotidienne chez le coronarien âgé. Arch Mal CœurVaiss 2015; 2015: 13-8.
  14. Depairon M, Stauffer I, Berthoud M, et al. Prévalence de l’athérosclérose subclinique chez l’adulte en suisse. J Mal Vasc2008 ; 33(S2) : 90.
  15. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of tenyear of fatal cardiovascular disease in Europe: the SCORE project. EurHeart J 2003; 24(11):987-1003.
  16. Brouri M, Ouadahi N, Nibouche D et al. Facteurs de risque cardio-vasculaires en Algérie. Une analyse du sous-groupede l’étude « Africa/Middle East CardiovascularEpidemiological» Annales de Cardiologie et d’Angiologie 2018 ; 67 : 61-66.
  17. Ikama SM, Nsitou BM, BouénizabilaEet al. Prévalence des lésions athéromateuses au cours du diabète sucré à Brazzaville, Congo. J Mal Vasc 2014; 39: 443-4.
  18. Gruson E, Dallongeville J. Définition des facteurs de risque cardiovasculaire selon les recommandations nationales. La Lettre de la Nouvelle Société Française d’Athérosclérose Internet 2007 consulté le12 Juillet 2015
  19. Houenassi DM, Houehanou C, Tchabi Y et al. Epidémiologie de l’artériopathie chronique oblitérante des membres inférieurs chez les porteurs d’hypertension artérielle au CHU de Cotonou. CardiologieTropicale2012 ; 33(135) :1-8.
  20. MakdisseM,the Heart of Brazil Project Group. Prevalence and risk factors associated with peripheral arterial disease in the hearts of Brazil project. Arq Bras Cardiol 2008 ; 91(6) : 370-82.
  21. Pessinaba S, Mbaye A, Kane AD et al. Dépistage de l’artériopathie oblitérante asymptomatique des membres inférieurs par la mesure de l’index de pression systolique dans la population générale de Saint-Louis (Sénégal). J Mal Vasc2012 ; 37 : 195-200.
  22. Muller M, Van Den Beld A, Bots M et al. Grobbee D, Lamberts S, Van Der SchowY.Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004 ; 109: 2074-9.
  23. Randimbinirina ZL, RajaobelisonT ,Rakotorahalahy R N A L et al . Cure chirurgicale des sténoses carotidiennes athéromateuses vues au Centre Hospitalier Universitaire Joseph RavoahangyAndrianavalona, Antananarivo Rev. Anesth.-Réanim. Med. Urg. Toxicol. 2018 ; 10(2) : 15-18.
  24. Stein JH, Korcarz CE, Hurst RT et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21(2): 93-111.